ADDEX THERAPEUTICS LTD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0716 CHF | +4.99% |
|
+3.47% | +55.65% |
| May. 08 | Addex to Present at BioEURquity Europe 2024 | DJ |
| Apr. 30 | European Equities Traded in the US as American Depositary Receipts Decline | MT |
Chart calendar Addex Therapeutics Ltd
21206d74735e2.jNEtp4yBShTk1cWUXZsZR3KYQ2ccKqGCkML4Lxh_cSs.9JQY5P_TO26UsPfHOPxvEBSrNT9NQJfv1rvPaFdOJVL0gRWU1vUDdpK2tg~637aacb6ad7d31581e12e09ff3671c4f
Upcoming events on Addex Therapeutics Ltd
Past events on Addex Therapeutics Ltd
| 2024-05-13 08:00 am | Bio Equity Europe Conference |
| 2024-04-23 07:45 am | Swiss Biotech Day |
| 2024-04-21 | Swiss Biotech Day |
| 2024-04-18 10:00 am | Q4 2023 Earnings Call |
| 2024-04-18 01:00 am | Q4 2023 Earnings Release |
| 2024-03-19 06:00 am | BioEurope Spring Conference |
| 2024-01-11 10:20 am | Swiss Equities Baader Conference |
| 2024-01-08 07:30 pm | Biotech Showcase |
| 2023-12-19 05:00 am | Extraordinary Shareholders Meeting |
| 2023-11-29 10:00 am | Q3 2023 Earnings Call |
| 2023-11-29 01:00 am | Q3 2023 Earnings Release |
| 2023-11-13 | Jefferies London Healthcare Conference |
| 2023-11-05 | Bio-Europe Conference |
| 2023-09-13 03:00 pm | H.C. Wainwright Global Investment Conference - Pre - Recorded |
| 2023-09-12 | SCI RSC Medicinal Chemistry Symposium |
| 2023-08-10 10:00 am | Q2 2023 Earnings Call |
| 2023-08-10 01:00 am | Q2 2023 Earnings Release |
| 2023-05-31 05:00 am | Annual General Meeting |
| 2023-05-13 | BioEquity Europe Conference |
| 2023-05-11 10:00 am | Q1 2023 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CHF | Released Forecast Spread | 2,76 3,49 -20.89% | 3,88 2,85 36.19% | 3,15 3,48 -9.29% | 1,45 1,15 25.65% | 1,65 1,10 49.73% | 1,50 |
|
EBITDA Million CHF | Released Forecast Spread | -14,3 -10,8 -32.13% | -11,9 -15,5 23.57% | -15,2 -15,6 2.52% | -20,2 -16,6 -22.04% | -9,98 -10,1 1.66% | -6,64 |
|
EBIT Million CHF | Released Forecast Spread | -14,6 -11,4 -28.12% | -12,2 -15,7 22.16% | -15,5 -15,6 0.31% | -20,5 -16,9 -21.64% | -10,3 -10,3 0.27% | -6,64 |
|
Earnings before Tax (EBT) Million CHF | Released Forecast Spread | -14,8 -11,0 -34.37% | -12,9 -16,2 20.62% | -15,4 -15,4 0.21% | -20,8 -17,0 -22.74% | -10,6 -11,3 6.58% | -4,80 |
|
Net income Million CHF | Released Forecast Spread | -14,8 -11,0 -34.37% | -12,9 -40,9 68.56% | -15,4 -15,4 0.21% | -20,8 -17,0 -22.74% | -10,6 -11,3 6.58% | -4,80 |
|
EPS CHF | Released Forecast Spread | -0,56 -0,42 -33.33% | -0,48 -0,62 22.58% | -0,45 -0,43 -3.85% | -0,46 -0,42 -10.84% | -0,14 -0,17 17.65% | -0,06 |
| Announcement Date | 08/04/20 | 11/03/21 | 10/03/22 | 30/03/23 | 18/04/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|
|
Net sales Million CHF | Released Forecast Spread | 0,40 0,48 -15.77% | 0,24 0,47 -48.09% | 0,19 0,51 -63.53% | 0,42 0,23 84.76% | 0,33 0,64 -48.67% | 0,15 0,65 -76.43% | |
|
EBIT Million CHF | Released Forecast Spread | -4,28 -4,30 0.67% | -5,76 -4,03 -43% | -7,09 -6,49 -9.28% | -4,17 -4,98 16.24% | -2,65 -2,31 -14.85% | -2,68 -2,55 -5.23% | |
|
Earnings before Tax (EBT) Million CHF | Released Forecast Spread | -4,42 -4,33 -2.24% | -5,82 -4,06 -43.63% | -7,22 -6,52 -10.84% | -4,11 -5,08 19.06% | -2,62 -2,43 -7.74% | -2,86 -2,65 -7.85% | |
|
Net income Million CHF | Released Forecast Spread | -4,42 -4,33 -2.24% | -5,82 -4,06 -43.63% | -7,22 -6,52 -10.84% | -4,11 -5,08 19.06% | -2,68 | -2,62 -2,43 -7.74% | -2,86 -2,65 -7.85% |
|
EPS CHF | Released Forecast Spread | -0,13 -0,10 -30% | -0,15 -0,08 -87.5% | -0,19 -0,13 -46.15% | -0,09 -0,09 0% | -0,04 | -0,03 -0,03 0% | -0,03 -0,03 0% |
| Announcement Date | 10/03/22 | 05/05/22 | 30/07/22 | 11/11/22 | 10/08/23 | 29/11/23 | 18/04/24 |
| 2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
| 2024-07-26 01:00 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Addex Therapeutics Ltd
| 2024-05-29 04:01 pm | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
| 2024-05-23 07:00 am | CUREVAC N.V.: Q1 2024 Earnings Release |
| 2024-05-22 01:00 am | EVOTEC SE: Q1 2024 Earnings Release |
| 2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
| 2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 am | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | KYVERNA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ADXN Stock
- Calendar Addex Therapeutics Ltd
